Synova Life Sciences
PrivateLast Round
Seed
Jun 30, 2023
Est. Valuation
$2.14M
Total Funding Raised
$2.16M
Company Overview
Synova Life Sciences operates in Healthcare & Life Sciences and is based in Pasadena, California. Its latest recorded funding round was a Seed round in June 2023.
Synova Life Sciences is a biotechnology company that develops medical devices to harvest autologous stem cells for therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synova Life Sciences Comparables
Compare Synova Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jointechlabs, Inc. | 87% | |
| InGeneron, Inc. | 85% | |
| Sayenza Biosciences | 85% |
For institutional investors. Book with your work email.
Synova Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 30, 2023 | ||||
| Seed | Aug 31, 2021 | ||||
| Accelerator | Apr 21, 2020 | ||||
| Accelerator | Mar 18, 2019 | ||||
| Accelerator | Nov 8, 2018 | ||||
Grant | Jul 5, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synova Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Accelerator |
| Creative Destruction Lab | Seed |
| Seraph Group | Seed |
| MassChallenge Israel | Seed |
| Y Combinator | Seed, Accelerator |
| Unpopular Ventures | Seed |
| Cox Communications | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2023
Seed round raised with Sand Hill Angels participating.
- Apr 21, 2020
Received funding from StartX.
For institutional investors. Book with your work email.
Synova Life Sciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synova Life Sciences's valuation, stock price, and market status.
Is Synova Life Sciences a public or private company?
Synova Life Sciences is a private company.
What is the current stock price of Synova Life Sciences?
Synova Life Sciences is a private company, so its shares have no public market price. Caplight tracks Synova Life Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synova Life Sciences worth (valuation)?
Synova Life Sciences's valuation is estimated at $2.1M based on funding round data.
Can I buy Synova Life Sciences stock?
Synova Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synova Life Sciences's last funding round?
Synova Life Sciences's most recent funding round was Seed on June 30, 2023.
Who are the main investors in Synova Life Sciences?
Key investors in Synova Life Sciences include Y Combinator.
Will Synova Life Sciences IPO soon?
No public IPO plans have been announced for Synova Life Sciences.
How can I track Synova Life Sciences secondary market activity?
Caplight tracks bids, offers, and trades in Synova Life Sciences's shares on secondary markets.